NCT07419841 2026-03-16A Phase 1 Study of the Safety and Tolerability of CTX-10726Compass TherapeuticsPhase 1 Not yet recruiting70 enrolled
NCT06724263 2024-12-09A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsTasly Biopharmaceuticals Co., Ltd.Phase 2 Not yet recruiting120 enrolled